A new classification for hepatocellular carcinoma with portal vein tumor thrombus

医学 肝细胞癌 门静脉 肝切除术 阶段(地层学) 回顾性队列研究 放射科 生存分析 血栓 存活率 胃肠病学 内科学 外科 切除术 古生物学 生物
作者
Jie Shi,Eric C. H. Lai,Nan Li,Wei‐Xing Guo,Jie Xue,Wan‐Yee Lau,Mengchao Wu,Shuqun Cheng
出处
期刊:Journal of Hepato-biliary-pancreatic Sciences [Wiley]
卷期号:18 (1): 74-80 被引量:185
标识
DOI:10.1007/s00534-010-0314-0
摘要

Abstract Background/purpose We aimed to correlate the survival of patients with hepatocellular carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent partial hepatectomy with or without portal thrombectomy with our PVTT classification. Currently, different staging systems for HCC are widely used in clinical practice. However, they lack the refinement in giving prognosis and guiding surgical treatment once macroscopic PVTT is present. Methods A retrospective study was carried out, in a single tertiary center, from January 2001 to December 2004 on 441 patients who underwent partial hepatectomy with or without portal thrombectomy for HCC with macroscopic PVTT. Overall survival was examined to determine whether it was correlated with our PVTT classification, and with the TNM staging, Cancer of the Liver Italian Program (CLIP) scoring system, and the Japan Integrated Staging (JIS) scoring system. Results With our PVTT classification, the numbers (percentages) of patients with types I, II, III, and IV PVTT were 144 (32.7%), 189 (42.9%), 86 (19.5%), and 22 (5.0%), respectively. The corresponding 1‐, 2‐, and 3‐year overall survival rates for types I to IV PVTT were 54.8, 33.9, and 26.7%; 36.4, 24.9, and 16.9%; 25.9, 12.9, and 3.7%; and 11.1, 0, and 0%, respectively (log‐rank of the survival curves p < 0.0001). Using the TNM system, the majority of patients were classified as stage III ( n = 379 or 85.9%). Similarly, the majority of patients ( n = 388 or 88.0%) were classified as having CLIP scores of 2 ( n = 143, or 32.4%), 3 ( n = 171, or 38.8%), and 4 ( n = 74, or 16.8%). The 1‐, 2‐, and 3‐year overall survivals for these 3 CLIP scores were very similar. Using the JIS score, the majority of patients ( n = 372 or 84.4%) were classified with a JIS score of 2. The 1‐, 2‐, and 3‐year overall survivals of patients with a JIS score of 2 were worse than those of the patients with a JIS score of 1 (this was expected) as well as being worse than those with a JIS score of 3 (this was unexpected). Thus, the latter 3 systems of classification were not refined enough, and they were inadequate for stratifying HCC with macroscopic PVTT treated with partial hepatectomy with or without thrombectomy. Conclusions In patients with HCC with macroscopic PVTT treated by partial hepatectomy with or without thrombectomy, our PVTT classification better stratified and predicted prognosis than the TNM staging, CLIP scoring system, and JIS scoring system, which were unrefined and inadequate for this group of patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Pk发布了新的文献求助10
刚刚
刚刚
只会发布了新的文献求助10
1秒前
1秒前
lixin完成签到,获得积分10
3秒前
wll发布了新的文献求助10
5秒前
5秒前
百变小茵完成签到,获得积分20
5秒前
只会完成签到,获得积分10
5秒前
5秒前
CipherSage应助CRane采纳,获得10
6秒前
Wqhao发布了新的文献求助10
7秒前
7秒前
7秒前
赘婿应助yy采纳,获得100
9秒前
搜集达人应助yanshenshen采纳,获得10
9秒前
12秒前
wanci应助百变小茵采纳,获得10
12秒前
陈巧玲完成签到,获得积分10
12秒前
乔治发布了新的文献求助10
12秒前
研友_VZG7GZ应助江楠采纳,获得10
14秒前
15秒前
雷霆康康完成签到,获得积分0
16秒前
16秒前
18秒前
18秒前
18秒前
mkljl完成签到,获得积分10
19秒前
19秒前
jwh111完成签到,获得积分10
21秒前
yin发布了新的文献求助10
22秒前
susu发布了新的文献求助10
22秒前
yzm发布了新的文献求助10
22秒前
CRane发布了新的文献求助10
24秒前
mkljl发布了新的文献求助20
25秒前
crx完成签到,获得积分10
25秒前
jwh111发布了新的文献求助10
25秒前
Owen应助big龙采纳,获得10
26秒前
李志侠发布了新的文献求助20
29秒前
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Salmon nasal cartilage-derived proteoglycan complexes influence the gut microbiota and bacterial metabolites in mice 2000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
ON THE THEORY OF BIRATIONAL BLOWING-UP 666
Signals, Systems, and Signal Processing 610
LASER: A Phase 2 Trial of 177 Lu-PSMA-617 as Systemic Therapy for RCC 520
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6382039
求助须知:如何正确求助?哪些是违规求助? 8194221
关于积分的说明 17322204
捐赠科研通 5435769
什么是DOI,文献DOI怎么找? 2875039
邀请新用户注册赠送积分活动 1851671
关于科研通互助平台的介绍 1696352